Lisata Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
11.83
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-0.77
|
-0.59
|
0.18
|
23.38%
|
|
2024-06-30
|
-0.76
|
-0.61
|
0.15
|
19.74%
|
|
2024-03-31
|
-0.72
|
-0.65
|
0.07
|
9.72%
|
|
2023-12-31
|
-0.89
|
-0.66
|
0.23
|
25.84%
|
|
2023-09-30
|
-0.93
|
-0.65
|
0.28
|
30.11%
|
|
2023-06-30
|
-0.70
|
-0.50
|
0.20
|
28.57%
|
|
2023-03-31
|
-0.81
|
-0.77
|
0.04
|
4.94%
|
|
2022-12-31
|
-1.01
|
-0.76
|
0.25
|
24.75%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-1.85
|
|
2023-12-31
|
-2.58
|
|
2022-12-31
|
-11.34
|
|
2021-12-31
|
-7.80
|
|
2020-12-31
|
-6.75
|
|
2019-12-31
|
-28.05
|
|
2018-12-31
|
-27.15
|
|
2017-12-31
|
-31.95
|
|
2016-12-31
|
-78.75
|
|
2015-12-31
|
-222.00
|
|
2014-12-31
|
-253.50
|
|
2013-12-31
|
-282.00
|
|
2012-12-31
|
-435.00
|
|
2011-12-31
|
-1350.00
|
|
2009-12-31
|
-4528.08
|
|
2008-12-31
|
-2334.88
|
|
2007-12-31
|
-20860.03
|
|
2005-12-31
|
-12830.07
|
|
2003-12-31
|
-70463.79
|